Tag: pancreatic cancer
May 13, 2019
AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study
AngioDynamics (NASDAQ:ANGO) has announced it has enrolled the first patient in its NanoKnife Irreversible Electroporation (IRE) “Data IRE Cancer Treatment”... April 3, 2019
TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer
Tyme Technologies (NASDAQ:TYME) has announced the closing of an underwritten registered offering with three existing investors and one new investor... February 25, 2019
TYME Receives FDA Guidance on Pivotal Trial for SM-88 in Treatment for Advanced Pancreatic Cancer
Tyme Technologies (NASDAQ:TYME) has announced it has received design guidance for a registrational trial from the US Food and Drug... May 7, 2018
Rexahn Reports First Quarter 2018 Financial Results
Rexahn Pharmaceuticals (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced financial...
April 30, 2018
8 Glioblastoma Treatment Stocks
With an average survival rate of 16 months, glioblastoma is the most common and deadly type of brain cancer, accounting...
April 18, 2018
Biotech Update: Q1 2018 in Review
With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the... April 16, 2018